Debunking the myths to provide 21st Century management of gout

New Zealand Medical Journal

Volumn 121, Issue 1274, 2008, Pages 79-85

  Winnard, Doone ^a,b   Kake, Tony ^b   Gow, Peter ^b   Barratt Boyes, Caran ^b   Harris, Victoria ^b   Hall, Devi Ann ^a   Mason, Henare ^a   Merriman, Tony ^c   Dalbeth, Nicola ^d  

^a Te Kaahui Ora Maaori Health Team   (New Zealand)

^b Department of Rheumatology ^*  (New Zealand)

^c UNIVERSITY OF OTAGO   (New Zealand)

^d Division of Medicine Emergency and Integrated Care   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; URIC ACID; ANTIGOUT AGENT;

ALCOHOL CONSUMPTION; ARTICLE; CARDIOVASCULAR DISEASE; COMMUNITY CARE; COMORBIDITY; DIABETES MELLITUS; DIET; DISABILITY; ETHNIC DIFFERENCE; GOUT; HAND FUNCTION; HEALTH BEHAVIOR; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; JOINT DEGENERATION; JOINT SURGERY; LIFESTYLE MODIFICATION; METABOLIC SYNDROME X; OVERNUTRITION; POSTOPERATIVE COMPLICATION; PREVALENCE; PRIMARY MEDICAL CARE; QUALITY OF LIFE; RECURRENT DISEASE; RISK FACTOR; URIC ACID BLOOD LEVEL; ABORIGINE; ADOLESCENT; ADULT; ATTITUDE TO HEALTH; CROSS-SECTIONAL STUDY; CULTURAL ANTHROPOLOGY; EARLY DIAGNOSIS; FORECASTING; HEALTH EDUCATION; HEALTH PROMOTION; LIFESTYLE; MALE; MIDDLE AGED; NEW ZEALAND; PRIMARY HEALTH CARE;

ADOLESCENT; ADULT; ALLOPURINOL; CROSS-SECTIONAL STUDIES; CULTURE; EARLY DIAGNOSIS; FORECASTING; GOUT; GOUT SUPPRESSANTS; HEALTH EDUCATION; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PROMOTION; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; NEW ZEALAND; OCEANIC ANCESTRY GROUP; PRIMARY HEALTH CARE; RISK FACTORS;

EID: 45149134198     PISSN: None     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Lindsay K. Grappling with gout in South Auckland. RACP News. Royal Australasian College of Physicians. August 2007:9.
2. Klemp P, Stansfield SA, Castle B, Robertson MC. Gout is on the increase in New Zealand. Ann Rheum Dis. 1997;56:22-6.
3. Baker JF, Krishnan E, Chen L, Schumacher HR. Serum uric acid and cardiovascular disease: Recent developments, and where do they leave us? Am J Med. 2005;118:816-26.
4. Krishnan E, Baker JF, Furst DE, Schumacher HR. Gout and the risk of acute myocardial infarction. Arthritis Rheum. 2006;54:2688-96.
5. Colvine K, Kerr A, McLachlan A, et al. Cardiovascular Risk Factor Assessment and Management in Gout: An Analysis Using Guideline Based Electronic Clinical Decision Support. In American College of Rheumatology Annual Scientific Meeting. Washington DC, USA; 2006.
6. Suppiah R, Dissanayake A, Dalbeth N. High prevalence of gout in patients with type 2 diabetes; male sex, renal impairment and diuretic use are major risk factors. In New Zealand Rheumatology Association Annual Scientific Meeting, Dunedin New Zealand; 2007
7. Dalbeth N, Collis J, Gregory K, et al. Tophaceous joint disease strongly predicts hand function in patients with gout. Rheumatology (Oxford). 2007;46(12):1804-7.
8. Janssens HJ, van de Lisdonk EH, Bor H, et al. Gout Just a nasty event or a cardiovascular signal? A study from primary care. Fam Pract. 2003;20:413-6.
9. Kumar S, Gow P. A survey of indications, results and complications of surgery for tophaceous gout. N Z Med J. 2002;115(1158). http://www.nzma.org.nz:8080/journal/115-1158/109
10. Dalbeth N, Gow P. Alcohol excess may be overemphasised in gout treated in secondary care. N Z Med J. 2006; 119(1243). http://www.nzma.org.nz:8080/journal/119-1243/2270
11. Gibson T, Waterworth R, Harfield P, et al. Hyperuricaemia, gout and kidney function in New Zealand Maori men. Br J Rheumatol. 1984;23:276-82.
12. Kleinman NL, Brook RA, Patel PA, et al. The impact of gout on work absence and productivity. Value Health. 2007;10:231-7.
13. Jones P. The modern management of gout. New Ethicals. 2001;4:29-31
14. Dalbeth N, Kumar S, Stamp L, Gow P. Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout. J Rheumatol. 2006; 33:1646-50.
15. Zhang W, Doherty M, Bardin T, et al. EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2006;65:1312-24.
16. Roddy E, Zhang W, Doherty M. Concordance of the management of chronic gout in a UK primary care population with the EULAR gout recommendations. Ann Rheum Dis. 2007;66:1311-5
17. Gow N, Gow P, Sahid H. Multidisciplinary care improves outcomes for patients with painful gout in South Auckland, New Zealand. Conference Proceedings 10th European Forum on Quality Improvement in Health Care 2005.